{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cholestasis", "Inflammation", "Liver diseases", "Nitric oxide", "Oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37736835", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1007/s00210-023-02684-2"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "397", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway.", "Pagination": {"StartPage": "1433", "EndPage": "1454", "MedlinePgn": "1433-1454"}, "Abstract": {"AbstractText": ["Cholestasis describes bile secretion or flow impairment, which is clinically manifested with fatigue, pruritus, and jaundice. Neutrophils play a crucial role in many diseases such as cholestasis liver diseases through mediating several oxidative and inflammatory pathways. Data have been collected from clinical, in vitro, and in vivo studies published between 2000 and December 2021 in English and obtained from the PubMed, Google Scholar, Scopus, and Cochrane libraries. Although nitric oxide plays an important role in the pathogenesis of cholestatic liver diseases, excessive levels of NO in serum and affected tissues, mainly synthesized by the inducible nitric oxide synthase (iNOS) enzyme, can exacerbate inflammation. NO induces the inflammatory and oxidative processes, which finally leads to cell damage. We found that natural products such as baicalin, curcumin, resveratrol, and lycopene, as well as chemical likes ursodeoxycholic acid, dexamethasone, rosuvastatin, melatonin, and sildenafil, are able to markedly attenuate the NO production and iNOS expression, mainly through inducing the nuclear factor \u03baB (NF-\u03baB), Janus kinase and signal transducer and activator of transcription (JAK/STAT), and toll like receptor-4 (TLR4) signaling pathways. This study summarizes the latest scientific data about the bile acid signaling pathway, the neutrophil chemotaxis recruitment process during cholestasis, and the role of NO in cholestasis liver diseases. Literature review directed us to propose that suppression of NO and its related pathways could be a therapeutic option for preventing or treating cholestatic liver diseases."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": ["0000-0003-0502-6114"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St., Tehran, Iran, P. O. Box: 19419-33111."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Lashgari", "ForeName": "Naser-Aldin", "Initials": "NA"}, {"Identifier": ["0000-0003-3318-9076"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St., Tehran, Iran, P. O. Box: 19419-33111."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Khayatan", "ForeName": "Danial", "Initials": "D"}, {"Identifier": ["0000-0003-1230-7969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St., Tehran, Iran, P. O. Box: 19419-33111."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Roudsari", "ForeName": "Nazanin Momeni", "Initials": "NM"}, {"Identifier": ["0000-0003-3957-3300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. dehpour@yahoo.com."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. dehpour@yahoo.com."}], "LastName": "Dehpour", "ForeName": "Ahmad Reza", "Initials": "AR"}, {"Identifier": ["0000-0001-9961-9097"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St., Tehran, Iran, P. O. Box: 19419-33111. amirhosein172@hotmail.com."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. amirhosein172@hotmail.com."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholestasis"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver Diseases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["metabolism"], "DescriptorName": "Liver"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ai G, Liu Q, Hua W, Huang Z, Wang D (2013) Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: in vitro and in vivo studies. J Ethnopharmacol 146:794\u2013802", "ArticleIdList": ["23422335"]}, {"Citation": "Aksu B, Umit H, Kanter M, Guzel A, Inan M, Civelek S, Aktas C, Uzun H (2009) Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. J Pediatr Surg 44:702\u2013710", "ArticleIdList": ["19361629"]}, {"Citation": "Ali FEM, Azouz AA, Bakr AG, Abo-Youssef AM, Hemeida RAM (2018) Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: the role of Keap-1/Nrf-2 and P38-MAPK/NF-\u03baB/iNOS signaling pathway. Food Chem Toxicol 120:294\u2013304", "ArticleIdList": ["30026087"]}, {"Citation": "Amirtharaj GJ, Natarajan SK, Anna Pulimood KA, Balasubramanian AV, Ramachandran A (2017) Role of oxygen free radicals, nitric oxide and mitochondria in mediating cardiac alterations during liver cirrhosis induced by thioacetamide. Cardiovasc Toxicol 17:175\u2013184", "ArticleIdList": ["27131982"]}, {"Citation": "Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, Kirimlioglu V, Yilmaz S (2005) Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res 127:112\u2013117", "ArticleIdList": ["16083749"]}, {"Citation": "Asai A, Miethke A, Bezerra JA (2015) Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol 12:342\u2013352", "ArticleIdList": ["26008129", "4877133"]}, {"Citation": "Awad AS, Kamel R (2010) Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers. J Biochem Mol Toxicol 24:89\u201394"}, {"Citation": "Bae HK, Lee H, Kim KC, Hong YM (2016) The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure. Korean J Pediatr 59:262", "ArticleIdList": ["27462355", "4958704"]}, {"Citation": "Barta A, Janega P, Bab\u00e1l P, Mur\u00e1r E, Cebov\u00e1 M, Pech\u00e1nov\u00e1 O (2015) The effect of curcumin on liver fibrosis in the rat model of microsurgical cholestasis. Food Funct 6:2187\u20132193", "ArticleIdList": ["26039974"]}, {"Citation": "Bian Ka, Murad F (2003) Nitric oxide (NO)-biogeneration, regulation, and relevance to human diseases. Front Biosci 8:264\u2013278"}, {"Citation": "Bull LN, Thompson RJ (2018) Progressive familial intrahepatic cholestasis. Clin Liver Dis 22:657\u2013669", "ArticleIdList": ["30266155"]}, {"Citation": "Castellani C, Assael BM (2017) Cystic fibrosis: a clinical view. Cell Mol Life Sci 74:129\u2013140", "ArticleIdList": ["27709245"]}, {"Citation": "Chen G, Ni Y, Nagata N, Zhuge F, Liang Xu, Nagashimada M, Yamamoto S, Ushida Y, Fuke N, Suganuma H (2019) Lycopene alleviates obesity-induced inflammation and insulin resistance by regulating M1/M2 status of macrophages. Mol Nutr Food Res 63:1900602"}, {"Citation": "Colares JR, Schemitt EG, Hartmann RM, Licks F, do Couto Soares M, Dal Bosco A, Marroni NP (2016) Antioxidant and anti-inflammatory action of melatonin in an experimental model of secondary biliary cirrhosis induced by bile duct ligation. World J Gastroenterol 22:8918", "ArticleIdList": ["27833383", "5083797"]}, {"Citation": "Crespo G, Mari\u00f1o Z, Navasa M, Forns X (2012) Viral hepatitis in liver transplantation. Gastroenterology 142(1373\u201383):e1"}, {"Citation": "De Boeck K, Amaral MD (2016) Progress in therapies for cystic fibrosis. Lancet Respir Med 4:662\u201374", "ArticleIdList": ["27053340"]}, {"Citation": "Der Woerd V, Wendy L, Houwen RHJ, van de Graaf SFJ (2017) Current and future therapies for inherited cholestatic liver diseases. World J Gastroenterol 23:763", "ArticleIdList": ["28223721", "5296193"]}, {"Citation": "Ding Y, Zhao L, Mei H, Zhang S-L, Huang Z-H, Duan Y-Y, Ye P (2008) Exploration of emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur J Pharmacol 590:377\u2013386", "ArticleIdList": ["18590720"]}, {"Citation": "Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG (2018) The role of statins in the management of nonalcoholic fatty liver disease. Curr Pharm Des 24:4587\u20134592", "ArticleIdList": ["30652643"]}, {"Citation": "Duvigneau JC, Luis A, Gorman AM, Samali A, Kaltenecker D, Moriggl R, Kozlov AV (2019) Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases. Cytokine 124:154577", "ArticleIdList": ["30446215"]}, {"Citation": "Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M (2018) Primary sclerosing cholangitis. Lancet 391:2547\u20132559", "ArticleIdList": ["29452711"]}, {"Citation": "Ezhilarasan D (2018) Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective. Arab J Gastroenterol 19:56\u201364", "ArticleIdList": ["29853428"]}, {"Citation": "Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi SM, Rahimi R, Abdollahi M (2018) Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 10:855", "ArticleIdList": ["29966389", "6073929"]}, {"Citation": "Fern\u00e1ndez-Mart\u00ednez E, Jim\u00e9nez-Santana M, Centeno-\u00c1lvarez M, Torres-Valencia JM, Shibayama M, Cari\u00f1o-Cort\u00e9s R (2017) Hepatoprotective effects of nonpolar extracts from inflorescences of thistles Cirsium vulgare and Cirsium ehrenbergii on acute liver damage in rat. Pharmacogn Mag 13:S860"}, {"Citation": "Galiniak S, Aebisher D, Bartusik-Aebisher D (2019) Health benefits of resveratrol administration. Acta Biochim Pol 66:13\u201321", "ArticleIdList": ["30816367"]}, {"Citation": "Galoosian A, Hanlon C, Zhang J, Holt EW, Yimam KK (2020) Clinical updates in primary biliary cholangitis: trends, epidemiology, diagnostics, and new therapeutic approaches. J Clin Transl Hepatol 8:49", "ArticleIdList": ["32274345", "7132015"]}, {"Citation": "Gossard AA, Talwalkar JA (2014) Cholestatic liver disease. Medical Clinics 98:73\u201385", "ArticleIdList": ["24266915"]}, {"Citation": "Grossi M, Phanstiel O, Rippe C, Sw\u00e4rd K, Alajbegovic A, Albinsson S, Forte A, Persson Lo, Hellstrand P, Nilsson B-O (2016) Inhibition of polyamine uptake potentiates the anti-proliferative effect of polyamine synthesis inhibition and preserves the contractile phenotype of vascular smooth muscle cells. J Cell Physiol 231:1334\u20131342", "ArticleIdList": ["26529275"]}, {"Citation": "Gunaydin M, Cil ATB (2018) Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepatic Med Evid Res 10:95"}, {"Citation": "Guo L-T, Wang S-Q, Jing Su, Li-Xing Xu, Ji Z-Y, Zhang R-Y, Zhao Q-W, Ma Z-Q, Deng X-Y, Ma S-P (2019) Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway. J Neuroinflammation 16:1\u201321"}, {"Citation": "Hasegawa S, Yoneda M, Kurita Y, Nogami A, Honda Y, Hosono K, Nakajima A (2021) Cholestatic liver disease: current treatment strategies and new therapeutic agents. Drugs 81:1181\u20131192", "ArticleIdList": ["34142342", "8282588"]}, {"Citation": "He L, Guo C, Peng C, Li Y (2021) Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review. Eur J Pharmacol 174447"}, {"Citation": "Hirschfield GM, Heathcote EJ, Gershwin ME (2010) Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 139:1481\u201396", "ArticleIdList": ["20849855"]}, {"Citation": "Hu C, Zhao L, Tao J, Li L (2019) Protective role of melatonin in early-stage and end-stage liver cirrhosis. J Cell Mol Med 23:7151\u20137162", "ArticleIdList": ["31475778", "6815834"]}, {"Citation": "Hu N, Liu J, Xue X, Li Y (2020) The effect of emodin on liver disease\u2013comprehensive advances in molecular mechanisms. Eur J Pharmacol 882:173269", "ArticleIdList": ["32553811"]}, {"Citation": "Huang F (2021) Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: effects on cell apoptosis, oxidative stress and inflammation in the brain. Brain Behav Immun-Health 100348"}, {"Citation": "Hussein MA (2013) Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis. J Med Food 16:246\u2013254", "ArticleIdList": ["23305807"]}, {"Citation": "Iwakiri Y, Kim MY (2015) Nitric oxide in liver diseases. Trends Pharmacol Sci 36:524\u2013536", "ArticleIdList": ["26027855", "4532625"]}, {"Citation": "Jansen PLM, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG (2017) The ascending pathophysiology of cholestatic liver disease. Hepatology 65:722\u2013738", "ArticleIdList": ["27981592"]}, {"Citation": "Jin F, Cheng Du, Tao J-Y, Zhang S-L, Pang R, Guo Y-J, Ye P, Dong J-H, Zhao L (2013) Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterol 13:1\u201310"}, {"Citation": "Karaman A, Iraz M, Kirimlioglu H, Karadag N, Tas E, Fadillioglu E (2006) Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. Pediatr Surg Int 22:701", "ArticleIdList": ["16896809"]}, {"Citation": "Karaman A, Kirimlioglu H, Tas E, Karadag N, G\u00fclsul C, Fadillioglu E, Demircan M (2010) Effect of leflunomide on liver regeneration after partial hepatectomy in rats. Pediatr Surg Int 26:219\u2013226", "ArticleIdList": ["20128110"]}, {"Citation": "Kim YP, Lee EB, Kim SY, Li D, Ban HS, Lim SS, Shin KH, Ohuchi K (2001) Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med 67:362\u2013364", "ArticleIdList": ["11458457"]}, {"Citation": "Kim T-W, Lee H-K, Song I-B, Kim M-S, Hwang Y-H, Lim J-H, Park S-J, Lee S-W, Kim J-W, Yun H-I (2012) Protective effect of the aqueous extract from the root of Platycodon grandiflorum on cholestasis-induced hepatic injury in mice. Pharm Biol 50:1473\u20131478", "ArticleIdList": ["23035893"]}, {"Citation": "Kim T-W, Lee H-K, Song I-B, Lim J-H, Cho E-S, Son H-Y, Jung J-Y, Yun H-I (2013) Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in mice. Food Chem Toxicol 51:364\u2013369", "ArticleIdList": ["23116642"]}, {"Citation": "Kohut TJ, Gilbert MA, Loomes KM (2021) Alagille syndrome: a focused review on clinical features, genetics, and treatment. In Seminars in liver disease. Thieme Medical Publishers, Inc."}, {"Citation": "Kosters A, Karpen SJ (2010) The role of inflammation in cholestasis: clinical and basic aspects. In Seminars in liver disease, 186\u201394. \u00a9 Thieme Medical Publishers"}, {"Citation": "Kozyra M, Glowniak K (2013) Phenolic acids in extracts obtained from the flowering herbs of Cirsium vulgare (Savi) Ten. growing in Poland. Acta Societatis Botanicorum Poloniae 82"}, {"Citation": "Labib PL, Goodchild G, Pereira SP (2019) Molecular pathogenesis of cholangiocarcinoma. BMC Cancer 19:1\u201316"}, {"Citation": "Lakshminarayanan B, Davenport M (2016) Biliary atresia: a comprehensive review. J Autoimmun 73:1\u20139", "ArticleIdList": ["27346637"]}, {"Citation": "Lashgari N-A, Momeni Roudsari N, Momtaz S, Ghanaatian N, Kohansal P, Hosein Farzaei M, Afshari K, Sahebkar A, Abdolghaffari AH (2020) Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases. Curr Med Chem"}, {"Citation": "Li T-H, Lee P-C, Lee K-C, Hsieh Y-C, Tsai C-Y, Yang Y-Y, Huang S-F, Tsai T-H, Hsieh S-L, Hou M-C (2016b) Down-regulation of common NF\u03baB-iNOS pathway by chronic thalidomide treatment improves hepatopulmonary syndrome and muscle wasting in rats with biliary cirrhosis. Sci Rep 6:1\u201314"}, {"Citation": "Li W, Jiang L, Xianzhou Lu, Liu X, Ling M (2021) Curcumin protects radiation-induced liver damage in rats through the NF-\u03baB signaling pathway. BMC Complement Med Ther 21:1\u201310"}, {"Citation": "Li S, Hong M, Tan H-Y, Wang N, Feng Y (2016a) Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxidative Med Cell Longev 2016a"}, {"Citation": "Lim JH, Kim TW, Song IB, Park SJ, Kim MS, Cho ES, Jung JY, Son HY, Kim JW, Yun HI (2013) Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats. Hum Exp Toxicol 32:1197\u20131205", "ArticleIdList": ["23424213"]}, {"Citation": "Liu J, Peng L, Yang J, Wang M, Shengnan Xu, Liu J, Han P, He J, Tian D, Zhou Qi (2015) Sodium ferulate reduces portal pressure through inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase in cirrhotic rats. Dig Dis Sci 60:2019\u20132029", "ArticleIdList": ["25724163"]}, {"Citation": "Lohse AW, Chazouilleres O, Dalekos G, Drenth J, Heneghan M, Hofer H, Lammert F, Lenzi M (2015) EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol 63:971\u20131004"}, {"Citation": "Lv P, Luo H-S, Zhou X-P, Paul SC, Xiao Y-J, Si X-M, Liu S-Q (2006) Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress. Pathol-Res Pract 202:777\u2013788", "ArticleIdList": ["17030452"]}, {"Citation": "Lv P, Li H-Y, Ji S-S, Li W, Fan L-J (2014) Thalidomide alleviates acute pancreatitis-associated lung injury via down-regulation of NF\u03baB induced TNF-\u03b1. Pathol-Res Pract 210:558\u2013564", "ArticleIdList": ["24939146"]}, {"Citation": "Lv H, Hong L, Tian Ye, Yin C, Zhu C, Feng H (2019) Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3\u03b2-Nrf2 signaling pathway. Cell Commun Signal 17:1\u201315"}, {"Citation": "Ma X, Jiang Y, Zhang W, Wang J, Wang R, Wang L, Wei S, Wen J, Li H, Zhao Y (2020) Natural products for the prevention and treatment of cholestasis: a review. Phytother Res 34:1291\u20131309", "ArticleIdList": ["32026542"]}, {"Citation": "Ma K, Tang D, Yu C, Zhao L (2021) Progress in research on the roles of TGR5 receptor in liver diseases. Scand J Gastroenterol 1\u201310"}, {"Citation": "Manns MP, Lohse AW, Vergani D (2015) Autoimmune hepatitis\u2013update 2015. J Hepatol 62:S100\u2013S111", "ArticleIdList": ["25920079"]}, {"Citation": "Mawardi M, Alalwan A, Fallatah H, Abaalkhail F, Hasosah M, Shagrani M, Alghamdi MY, Alghamdi AS (2021) Cholestatic liver disease: practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation. Saudi J Gastroenterol 27:S1", "ArticleIdList": ["8411950"]}, {"Citation": "Mazzetti M, Marconi G, Mancinelli M, Benedetti A, Marzioni M, Maroni L (2021) The management of cholestatic liver diseases: current therapies and emerging new possibilities. J Clin Med 10:1763", "ArticleIdList": ["33919600", "8073106"]}, {"Citation": "Michielsen PP, Francque SM, van Dongen JL (2005) Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 3:1\u201318"}, {"Citation": "Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ (2018) Autoimmune hepatitis. Nat Rev Dis Primers 4:1\u201321"}, {"Citation": "Mitchell E, Gilbert M, Loomes KM (2018) Alagille syndrome. Clin Liver Dis 22:625\u2013641", "ArticleIdList": ["30266153"]}, {"Citation": "Mladenovi\u0107 B, Mladenovi\u0107 N, Brza\u010dki V, Petrovi\u0107 N, Kamenov A, Golubovi\u0107 M, Ni\u010dkovi\u0107 V, Stojanovi\u0107 NM, Sokolovi\u0107 DT (2018) Exogenous putrescine affects polyamine and arginine metabolism in rat liver following bile ductus ligation. Can J Physiol Pharmacol 96:1232\u20131237", "ArticleIdList": ["30193084"]}, {"Citation": "Murch O, Abdelrahman M, Collino M, Gallicchio M, Benetti E, Mazzon E, Fantozzi R, Cuzzocrea S, Thiemermann C (2008) Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat. Crit Care Med 36:550\u2013559", "ArticleIdList": ["18216604"]}, {"Citation": "Oleshchuk O, Ivankiv Y, Falfushynska H, Mudra A, Lisnychuk N (2019) Hepatoprotective effect of melatonin in toxic liver injury in rats. Medicina 55:304", "ArticleIdList": ["31238587", "6631928"]}, {"Citation": "Olteanu D, Filip A, Mure\u015fan A, Nagy A, Tabaran F, Moldovan R, Decea N, Catoi C, Clichici S (2012) The effects of chitosan and low dose dexamethasone on extrahepatic cholestasis after bile duct ligation in Wistar rats. Acta Physiol Hung 99:61\u201373", "ArticleIdList": ["22425809"]}, {"Citation": "Osna NA, Donohue Jr TM, Kharbanda KK (2017) Alcoholic liver disease: pathogenesis and current management. Alcohol Res Curr Rev 38:147"}, {"Citation": "Pinto C, Giordano DM, Maroni L, Marzioni M (2018) Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology. Biochim Biophys Acta Mol Basis Dis 1864:1270\u201378", "ArticleIdList": ["28754451"]}, {"Citation": "Rabiee A, Silveira MG (2021) Primary sclerosing cholangitis. Transl Gastroenterol Hepatol 6"}, {"Citation": "Rafeeq MM, Murad HAS (2017) Cystic fibrosis: current therapeutic targets and future approaches. J Transl Med 15:1\u20139"}, {"Citation": "Razori MV, Maidagan PM, Ciriaci N, Andermatten RB, Barosso IR, Mart\u00edn PL, Basiglio CL, S\u00e1nchez Pozzi EJ, Ruiz ML, Roma MG (2019) Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis. Biochem Pharmacol 168:48\u201356", "ArticleIdList": ["31202734"]}, {"Citation": "Roesch EA, Nichols DP, Chmiel JF (2018) Inflammation in cystic fibrosis: an update. Pediatr Pulmonol 53:S30\u2013S50", "ArticleIdList": ["29999593"]}, {"Citation": "Rolla G, Brussino L, Scappaticci E, Morello M, Innarella R, Rosina F, Bucca C (2004) Source of exhaled nitric oxide in primary biliary cirrhosis. Chest 126:1546\u20131551", "ArticleIdList": ["15539725"]}, {"Citation": "Roudsari NM, Lashgari N-A, Zandi N, Pazoki B, Momtaz S, Sahebkar A, Abdolghaffari AH (2020) PPAR\u03b3: a turning point for irritable bowel syndrome treatment. Life Sci 118103"}, {"Citation": "Rutherford AE, Pratt DS (2006) Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 22:209\u2013214", "ArticleIdList": ["16550034"]}, {"Citation": "Saleh H, El-Shorbagy HM (2020) \u2019Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-\u03b1 and TGF-\u03b2 Expression. Int J Biol Macromol 164:1565\u20131574", "ArticleIdList": ["32735924"]}, {"Citation": "Samant H, Manatsathit W, Dies D, Shokouh-Amiri H, Zibari G, Boktor M, Alexander JS (2019) Cholestatic liver diseases: an era of emerging therapies. World J Clin Cases 7:1571", "ArticleIdList": ["31367616", "6658370"]}, {"Citation": "Shafaroodi H, Ebrahimi F, Moezi L, Hashemi M, Doostar Y, Ghasemi M, Dehpour AR (2010) Cholestasis induces apoptosis in mice cardiac cells: the possible role of nitric oxide and oxidative stress. Liver Int 30:898\u2013905", "ArticleIdList": ["20492516"]}, {"Citation": "Shen K, Feng X, Pan H, Zhang F, Xie H, Zheng S (2017) Baicalin ameliorates experimental liver cholestasis in mice by modulation of oxidative stress, inflammation, and NRF2 transcription factor. Oxidative Med Cell Longev 2017"}, {"Citation": "Spinner NB, Gilbert MA, Loomes KM, Krantz ID (2019) Alagille syndrome. GeneReviews\u00ae[Internet]"}, {"Citation": "Spirl\u00ec C, Okolicsanyi L, Strazzabosco M (2020) Effects of cytokines and nitric oxide on bicarbonate secretion by cholangiocytes. in, The pathophysiology of biliary epithelia (CRC Press)"}, {"Citation": "St\u00e4ttermayer AF, Halilbasic E, Wrba F, Ferenci P, Trauner M (2020) Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. J Hepatol 73:651\u2013663", "ArticleIdList": ["32376413"]}, {"Citation": "Staud R (2011) Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin 37:9\u201317"}, {"Citation": "Su T-H, Kao J-H, Liu C-J (2014) Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. Int J Mol Sci 15:10578\u201310604", "ArticleIdList": ["24927147", "4100170"]}, {"Citation": "Taghizadieh M, Hajipour B, Asl NA, Khodadadi A, Somi MH, Banei M (2016) Combination effect of melatonin and dexamethasone on liver ischemia/reperfusion injury. Bratisl Lek Listy 117:47\u201353", "ArticleIdList": ["26810170"]}, {"Citation": "Thuy V, Thi T, Thuy LTT, Yoshizato K, Kawada N (2017) Possible involvement of nitric oxide in enhanced liver injury and fibrogenesis during cholestasis in cytoglobin-deficient mice. Sci Rep 7:1\u201314"}, {"Citation": "Toka\u00e7 M, Taner G, Ayd\u0131n S, \u00d6zkarde\u015f AB, D\u00fcndar HZ, Ta\u015fl\u0131p\u0131nar MY, Ar\u0131k\u00f6k AT, K\u0131l\u0131\u00e7 M, Ba\u015faran AA, Basaran N (2013) Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. Food Chem Toxicol 61:28\u201335", "ArticleIdList": ["23376509"]}, {"Citation": "Tokac M, Aydin S, Taner G, \u00d6zkarde\u015f AB, Ta\u015flipinar MY, Do\u011fan M, D\u00fcndar HZ, Kilic M, Ba\u015faran AA, Ba\u015faran AN (2015) Hepatoprotective and antioxidant effects of lycopene in acute cholestasis. Turkish J Med Sci 45:857\u2013864"}, {"Citation": "Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C (2017) Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 15:434\u2013443", "ArticleIdList": ["28503116", "5405617"]}, {"Citation": "Trauner M, Fuchs CD (2022) Novel therapeutic targets for cholestatic and fatty liver disease. Gut 71:194\u2013209", "ArticleIdList": ["34615727"]}, {"Citation": "Vairetti M, Pasqua LGD, Cagna M, Richelmi P, Ferrigno A, Berardo C (2021) Changes in glutathione content in liver diseases: an update. Antioxidants 10:364", "ArticleIdList": ["33670839", "7997318"]}, {"Citation": "Wang Y, Xiong Y, Zhang A, Zhao N, Zhang J, Zhao D, Zhenhai Yu, Ning Xu, Yin Y, Luan X (2020) Oligosaccharide attenuates aging-related liver dysfunction by activating Nrf2 antioxidant signaling. Food Sci Nutr 8:3872\u20133881", "ArticleIdList": ["32724648", "7382186"]}, {"Citation": "Wang Y, Zhu L, Duo Xu, Gao L, Li Y, Liang B, Zhang X, Yue Y (2021) Intrahepatic cholestasis of pregnancy is associated with reduced nitric oxide synthase (iNOS) in plasma and placentas: a pilot study. Med Sci Monit 27:e930176\u2013e930181", "ArticleIdList": ["33846282", "8052913"]}, {"Citation": "Wei L, Yang J, Wang M, Sheng-Nan Xu, Liang H-M, Zhou Qi (2014) Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study. Int J Mol Med 34:1257\u20131267", "ArticleIdList": ["25174394", "4199412"]}, {"Citation": "Wiering L, Tacke F (2023) Treating inflammation to combat non-alcoholic fatty liver disease. J Endocrinol 256"}, {"Citation": "Williamson KD, Chapman RW (2016) New therapeutic strategies for primary sclerosing cholangitis. In Seminars in liver disease, 005\u201314. Thieme Medical Publishers"}, {"Citation": "Yan J-Y, Ai G, Zhang X-J, Hai-Jiang Xu, Huang Z-M (2015) Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against \u03b1-naphthylisothiocyanate-induced cholestatic liver injury in rats. J Ethnopharmacol 172:202\u2013213", "ArticleIdList": ["26133062"]}, {"Citation": "Yardimci S, Bostanci EB , Ozer I, Dalgic T, Surmelioglu A, Aydog G, Akoglu M (2012) Sildenafil accelerates liver regeneration after partial hepatectomy in rats. In Transplantation proceedings, 1747\u201350. Elsevier"}, {"Citation": "Yokoda RT, Rodriguez EA (2020) Pathogenesis of cholestatic liver diseases. World J Hepatol 12:423", "ArticleIdList": ["32952871", "7475774"]}, {"Citation": "Zhang P, Li J, Li M, Sui Y, Zhou Y, Sun Y (2020) Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats. Wei Sheng Yan Jiu 49:254\u201371", "ArticleIdList": ["32290942"]}, {"Citation": "Zhang R, Chu K, Zhao N, Jingjing Wu, Ma L, Zhu C, Chen X, Wei G, Liao M (2020b) Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL/6 mice by ameliorating oxidative stress and restoring autophagic flux. Front Pharmacol 10:1693", "ArticleIdList": ["32116684", "7011087"]}, {"Citation": "Zhao HL, Harding SV, Marinangeli CPF, Kim YS, Jones PJH (2008) Hypocholesterolemic and anti-obesity effects of saponins from Platycodon grandiflorum in hamsters fed atherogenic diets. J Food Sci 73:H195\u2013H200", "ArticleIdList": ["19019115"]}, {"Citation": "Zheng Y, Zhang R, Shi W, Li L, Liu H, Chen Z, Longhuo Wu (2020) Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food Funct 11:8472\u20138492", "ArticleIdList": ["32966476"]}, {"Citation": "Zhou L, An X-F, Teng S-C, Liu J-S, Shang W-B, Zhang A-H, Yuan Y-G, Jiang-Yi Yu (2012) Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 15:461\u2013468", "ArticleIdList": ["22439874", "3338104"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "20"}, {"Year": "2023", "Month": "8", "Day": "21"}, {"Year": "2024", "Month": "2", "Day": "11", "Hour": "7", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "22", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "22", "Hour": "6", "Minute": "46"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37736835", "10.1007/s00210-023-02684-2", "10.1007/s00210-023-02684-2"]}}], "PubmedBookArticle": []}